MyFinsight
Home
Blog
About
Accounts receivable, net
$1,167,571
(264.36%↑ Y/Y)
Cash
$449,325
(42.03%↑ Y/Y)
Inventory, net
$269,518
(62.54%↑ Y/Y)
Prepaid expenses and
other current assets
$107,021
(111.21%↑ Y/Y)
Property, plant, and
equipment, gross
$1,138,493
(35.31%↑ Y/Y)
Total current assets
$1,993,435
(133.62%↑ Y/Y)
Property and equipment,
net
$571,735
(54.45%↑ Y/Y)
Operating lease right of
use assets
$61,120
(-55.07%↓ Y/Y)
Less accumulated
depreciation
$566,758
(20.27%↑ Y/Y)
Total assets
$2,626,290
(93.18%↑ Y/Y)
Accumulated deficit
-$35,668,229
(-5.98%↓ Y/Y)
Total liabilities and
stockholders' deficit
$2,626,290
(93.18%↑ Y/Y)
Total stockholders'
deficit
-$1,535,314
(-86.20%↓ Y/Y)
Additional paid-in capital
$34,128,073
(3.96%↑ Y/Y)
Common stock 0.0001 par
value, 100,000,000...
$4,842
(3.40%↑ Y/Y)
Total liabilities
$4,161,604
(90.55%↑ Y/Y)
Total current
liabilities
$1,554,001
(55.56%↑ Y/Y)
Notes
payable-Nonrelated Party
$1,436,250
Deferred revenue long
term
$857,353
(-23.79%↓ Y/Y)
Notes
payable-Related Party
$314,000
Accrued expenses
$619,046
(96.80%↑ Y/Y)
Accounts payable
$563,100
(79.97%↑ Y/Y)
Deferred revenue
$311,765
(3.92%↑ Y/Y)
Current portion of
operating lease...
$60,090
(-15.98%↓ Y/Y)
Back
Back
Balance Sheet
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)
source: myfinsight.com